Nonalcoholic Steatohepatitis (NASH)
Part of Gastroenterology & Hepatology
🏥1Companies
Companies in Nonalcoholic Steatohepatitis (NASH)
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
BenevolentAI
London, UK
BenevolentAI, founded in 2013 and headquartered in London, United Kingdom, is a drug discovery company that was delisted from Euronext Amsterdam and merged with Osaka Holdings S...
...moreBusiness ModelB2B (collaborations with pharmaceutical companies, commercializing knowledge exploration tools), In-house drug development (advancing own drug pipeline).
Core TechBenevolent Platform™ - an end-to-end computational and ex...
Funding$282.0M
Founded2013
Drug Discovery/Development
59